2. INTRODUCTION-
• THE DRUGS WHICH ARE USED IN THE
TREATMENT OF TUBERCULOSIS ARE
CALLED ANTITUBERCULAR DRUGS .
3. CLASSIFICATION-
• ACCORDING TO THEIR CLINICAL UTILITY THE
ANTITUBERCULAR DRUGS CAN BE DIVIDED
INTO-
• FIRST LINE DRUGS - THESE DRUGS HAVE HIGH
ANTITUBERCULAR EFFICACY AS WELL AS LOW
TOXICITY ARE USED ROUTINELY
• SECOND LINE DRUGS – THESE DRUGS HAVE
EITHER LOW ANTITUBERCULAR EFFICACY OR
HIGHER TOXICITY OR BOTH AND ARE USED AS
RESERVE DRUGS.
4. FIRST LINE DRUGS -
• ISONIAZID
• RIFAMPIN
• PYRAZINAMIDE
• ETHAMBUTOL
• STREPTOMYCIN
6. ISONIAZID -
• IT IS PRIMARILY TUBERCULOCIDAL .
• ISONIAZID INHIBTS SYNTHESIS OF MYCOLIC
ACIDS , WHICH ARE ESSENTIAL COMPONENTS
OF MYCOBECTERIAL CELL WALLS
• PHARMACOKINETICS – INH IS COMPLETELY
ABSORBED ORALLY AND PENETRATES ALL
BODY TISSUES , TUBERCULAR CAVITIES ,
PLACENTA AND MENINGES.
7. CONT…
• METABOLISM- THE RATE OF INH ACETYLATION
SHOWS GENETIC VARIATION
• ADVERSE EFFECTS –
-HEPATITIS
-HEPATOTOXICITY
PERIPHERAL NEURITIS
8. RIFAMPIN -
• BACTERIOCIDAL
• ACTS BEST ON SLOWLY OR INTERMITTENTLY
DIVIDING ONES
• BOTH EXTA AND INTACELLULAR ORGANISMS
ARE AFFECTED
• RIFAMPIN BINDS TO BACTERIAL DNA
DEPENDENT RNA POLYMERASE AND
THEREBY INHIBITS RNA SYNTHESIS
9. CONT…
• PHARMACOKINETICS – IT IS WELL ABSORBED
ORALLY . RIFAMPIN IS TO BE TAKEN IN EMPTY
STOMACH
• INTERACTIONS – RIFAMPICIN IS A
MICROSOMAL ENZYME INDUCER
10. CONT…
• ADVERSE EFFECT-
• CUTENEOUS SYNDROME
• FLU SYNDROME
• ABDOMINAL SYNDROME
• URINE AND SECRETIONS MAY BECOME
ORANGE , RED BUT THIS IS HARMLESS
11. PYRAZINAMIDE -
• CHEMICALLY SIMILAR TO INH .
• IT IS WEAKLY TUBERCULOCIDAL
• MORE ACTIVE IN ACIDIC MEDIUM
• INHIBIT MYCOLIC ACID SYNTHESIS (CELL
WALL SYNTHESIS INHIBITION)
16. SOME IMPORTANT POINTS-
• ALL FIRST LINE DRUGS ARE BACTERIOCIDAL
EXCEPT -ETHAMBUTOL
• MOST POTENT FIRST LINE DRUG -RIFAMPIN
• DRUG ACTING WEL IN ACIDIC AND
INTRACELLULAR ENVIRONMENT –
PYRAZINAMIDE
17. NURSING RESPONSIBILITY-
• CARING WITH BEST ATTENTION ON
MEDICATION
• NURSES ARE PRIMARY RESPONSIBLE FOR
DIRECT OBSERVATION THERAPY STRATEGY
AND ADMINISTRATION OF ANTI
TUBERCULOSIS
• IDENTIFY SYMPTOMS THAT MAY INDICATE A
SIDE EFFECT